Increasingly, primary hypertension is being considered a syndrome and not a disease, with
the individual causes (diseases) having a common sign—an elevated blood pressure. To …

Resistant hypertension, defined as blood pressure that remains above goal despite using
three or more antihypertensive medications, including a diuretic, affects a significant …

Numerous genetic variants associated with hypertension and blood pressure are known, but
there is a paucity of evidence from genetic studies of resistant hypertension, especially in …

Mineralocorticoid-receptor antagonists (MRAs) have proven to be effective in some types of
hypertension, especially in resistant hypertension (RHTN). In this phenotype of …

INTRODUCTION Precision medicine has the potential to improve current standard of care
for patients, especially in the cardiovascular field. Better prevention and treatment of …

Resistant hypertension (RH) is a concept that currently goes beyond the classical definition
of blood pressure≥ 140/90 mmHg in subjects receiving three or more drugs of different …

This study investigated the renin-angiotensin-aldosterone system (RAAS) gene
polymorphisms as possible genetic risk factors for the restenosis development in patients …

Resistant hypertension (RHTN) consists in a condition where blood pressure (BP) levels
remain uncontrolled despite the use of at least three drugs or if the control happens with four …

Resistant hypertension (RHTN), defined as an uncontrolled blood pressure despite the use
of multiple antihypertensive medications, is an increasing clinical problem associated with …

OBJECTIVES Genetic polymorphisms on mineralocorticoid receptor gene (NC3C2) are
associated with variability of mineralocorticoid receptor (MR) function and cardiovascular …